WebRecursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. ... Blake Borgeson Ph.D: Recursion ... WebBlake Borgeson is Board Member at Recursion Pharmaceuticals Inc. See Blake Borgeson's compensation, career history, education, & memberships.
Recursion Pharmaceuticals - EverybodyWiki Bios & Wiki
WebJul 25, 2024 · They were joined by a third co-founder, bioinformatician Blake Borgeson. ... Recursion hopes the data set will spur outside researchers to develop new machine learning techniques. WebApr 5, 2024 · The estimated net worth of Blake Borgeson is at least $48.64 million as of March 21st, 2024. Dr. Borgeson owns 7,576,287 shares of Recursion Pharmaceuticals … mayhew actor
Blake Borgeson on LinkedIn: Today is the day that Recursion …
WebApr 4, 2024 · RXRX Recursion Pharmaceuticals Inc Report of Proposed Sale of Securities (144) ... Blake Borgeson 41 S Rio Grande Street Salt Lake City UTAH 84101: Class A: … WebDec 3, 2024 · Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) Director Blake Borgeson sold 8,885 shares of the business’s stock in a transaction on Tuesday, November 29th. The shares were sold at an average price of $8.75, for a total transaction of $77,743.75. Following the completion of the transaction, the director now directly owns … WebThe Registered Agent on file for this company is C T Corporation System and is located at 1999 Bryan St., Ste. 900, Dallas, TX 75201-3136. The company has 8 contacts on record. The contacts are Blake Borgeson from Salt Lake City UT, Christopher Gibson from Salt Lake City UT, Dean Y Li from Salt Lake City UT, R Martin Chavez from Salt Lake City ... hertz brittain rd akron oh